Top Markets
Coin of the day
Allergy Therapeutics plc Allergy Therapeutics plc

Allergy Therapeutics plc

AGY
Rank in Stocks #35053
Allergy Therapeutics plc is a biotechnology firm dedicated to the research and... Allergy Therapeutics plc is a biotechnology firm dedicated to the research and development of innovative treatments for allergies. The company offers a range of injectable and sublingual immunotherapies specifically targeting allergens, alongside diagnostic tools and prescription solutions for pollen-related allergies, including those caused by grasses, weeds, and trees. Its diverse product portfolio features Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. Furthermore, Allergy Therapeutics is actively advancing new vaccine candidates designed to address sensitivities to trees, grass, house dust mites, animal dander, and peanuts. With operations spanning Central Europe, Southern Europe, the United Kingdom, and various other international markets, Allergy Therapeutics plc was established in 2004 and is headquartered in Worthing, UK.
Share Price
$0.07143683
Last synced: 2026-08-14
Market Cap
$4.52M
Change (1 day)
0.00%
Change (1 year)
-37.27%
Country
GB
Trade Allergy Therapeutics plc (AGY)

Category

Stock split history for Allergy Therapeutics plc (AGY)
Allergy Therapeutics plc stock (symbol: AGY) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 16, 2026.
One AGY share bought prior to Aug 16, 2026 would equal to 0 AGY shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors